Identification of cancer protein biomarkers using proteomic techniques
Abstract
The claimed invention describes methods to diagnose or aid in the diagnosis of cancer. The claimed methods are based on the identification of biomarkers which are particularly well suited to discriminate between cancer subjects and healthy subjects. These biomarkers were identified using a unique and novel screening method described herein. The biomarkers identified herein can also be used in the prognosis and monitoring of cancer. The invention comprises the use of leptin, prolactin, OPN and IGF-II for diagnosing, prognosis and monitoring of ovarian cancer.
- Inventors:
- Issue Date:
- Research Org.:
- Yale Univ., New Haven, CT (United States)
- Sponsoring Org.:
- USDOE
- OSTI Identifier:
- 1493331
- Patent Number(s):
- 10168334
- Application Number:
- 15/268,134
- Assignee:
- Yale University (New Haven, CT)
- Patent Classifications (CPCs):
-
C - CHEMISTRY C12 - BIOCHEMISTRY C12Q - MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS
G - PHYSICS G01 - MEASURING G01N - INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- DOE Contract Number:
- FG02-ER63462
- Resource Type:
- Patent
- Resource Relation:
- Patent File Date: 2016 Sep 16
- Country of Publication:
- United States
- Language:
- English
- Subject:
- 60 APPLIED LIFE SCIENCES
Citation Formats
Mor, Gil G., Ward, David C., and Bray-Ward, Patricia. Identification of cancer protein biomarkers using proteomic techniques. United States: N. p., 2019.
Web.
Mor, Gil G., Ward, David C., & Bray-Ward, Patricia. Identification of cancer protein biomarkers using proteomic techniques. United States.
Mor, Gil G., Ward, David C., and Bray-Ward, Patricia. Tue .
"Identification of cancer protein biomarkers using proteomic techniques". United States. https://www.osti.gov/servlets/purl/1493331.
@article{osti_1493331,
title = {Identification of cancer protein biomarkers using proteomic techniques},
author = {Mor, Gil G. and Ward, David C. and Bray-Ward, Patricia},
abstractNote = {The claimed invention describes methods to diagnose or aid in the diagnosis of cancer. The claimed methods are based on the identification of biomarkers which are particularly well suited to discriminate between cancer subjects and healthy subjects. These biomarkers were identified using a unique and novel screening method described herein. The biomarkers identified herein can also be used in the prognosis and monitoring of cancer. The invention comprises the use of leptin, prolactin, OPN and IGF-II for diagnosing, prognosis and monitoring of ovarian cancer.},
doi = {},
journal = {},
number = ,
volume = ,
place = {United States},
year = {2019},
month = {1}
}
Works referenced in this record:
The role of Osteopontin in tumor metastasis
journal, October 2004
- Wai, Philip Y.; Kuo, Paul C.
- Journal of Surgical Research, Vol. 121, Issue 2, p. 228-241
Osteopontin is a potential target gene in mouse mammary cancer chemoprevention by Se-methylselenocysteine
journal, July 2004
- Unni, Emmanual; Kittrell, Frances S.; Singh, Uma
- Breast Cancer Research, Vol. 6, Issue 5
Multiplexed protein profiling on microarrays by rolling-circle amplification
journal, April 2002
- Schweitzer, Barry; Roberts, Scott; Grimwade, Brian
- Nature Biotechnology, Vol. 20, Issue 4, p. 359-365
Combining CA 125 and SMR serum markers for diagnosis and early detection of ovarian carcinoma
journal, October 2004
- McIntosh, M. W.; Drescher, C.; Karlan, B.
- Gynecologic Oncology, Vol. 95, Issue 1, p. 9-15
Bioinformatically detectable group of novel regulatory genes and uses thereof
patent, April 2012
- Bentwich, Itzhak
- US Patent Document 8,163,896
No association between serum levels of insulin-like growth factor-I, vascular endothelial growth factor, prolactin and clinicopathological characteristics of breast carcinoma after surgery: Serum levels and breast cancer
journal, June 2004
- Sancak, B.; Coskun, U.; Gunel, N.
- Internal Medicine Journal, Vol. 34, Issue 6
Utility of osteopontin as a biomarker in recurrent epithelial ovarian cancer
journal, May 2004
- Brakora, K.; Lee, H.; Yusuf, R.
- Gynecologic Oncology, Vol. 93, Issue 2
Identification of cancer protein biomarkers using proteomic techniques
patent, March 2015
- Mor, Gil G.; Ward, David C.; Bray-Ward, Patricia
- US Patent Document 8,975,379
Progress and Challenges in Screening for Early Detection of Ovarian Cancer
journal, February 2004
- Jacobs, Ian J.; Menon, Usha
- Molecular & Cellular Proteomics, Vol. 3, Issue 4
Prolactin acts as a potent survival factor for human breast cancer cell lines
journal, June 2004
- Perks, C. M.; Keith, A. J.; Goodhew, K. L.
- British Journal of Cancer, Vol. 91, Issue 2
Elevated leptin concentrations in pregnancy and lactation: Possible role as a modulator of substrate utilization
journal, August 1999
- Mukherjea, Ratna; Castonguay, Thomas W.; Douglass, Larry W.
- Life Sciences, Vol. 65, Issue 11
The metastasis gene osteopontin: a candidate target for cancer therapy
journal, December 2001
- Weber, Georg F.
- Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, Vol. 1552, Issue 2
Enhanced Expression of Leptin and Leptin Receptor (OB-R) in Human Breast Cancer
journal, July 2004
- Ishikawa, Makoto; Kitayama, Joji; Nagawa, Hirokazu
- Clinical Cancer Research, Vol. 10, Issue 13
Expression of Leptin Receptors and Potential Effects of Leptin on the Cell Growth and Activation of Mitogen-Activated Protein Kinases in Ovarian Cancer Cells
journal, January 2005
- Choi, Jung-Hye; Park, Se-Hyung; Leung, Peter C. K.
- The Journal of Clinical Endocrinology & Metabolism, Vol. 90, Issue 1
Plasma Prolactin Concentrations and Risk of Postmenopausal Breast Cancer
journal, September 2004
- Tworoger, Shelley S.; Eliassen, A. Heather; Rosner, Bernard
- Cancer Research, Vol. 64, Issue 18
Ovarian dysgerminoma showing high serum levels and positive immunostaining of placental alkaline phosphatase and neuron-specific enolase associated with elevation of serum prolactin level
journal, October 1998
- Yoshida, Masumi; Koshiyama, Masafumi; Konishi, Mitsunaga
- European Journal of Obstetrics & Gynecology and Reproductive Biology, Vol. 81, Issue 1, p. 123-128
Methods and compositions for diagnosing and monitoring transplant rejection
patent, April 2006
- Wohlgemuth, Jay; Fry, Kirk; Woodward, Robert
- US Patent Document 7,026,121
Prolactin increases HO-1 expression and induces VEGF production in human macrophages
journal, January 2004
- Malaguarnera, L.; Imbesi, R. M.; Scuto, A.
- Journal of Cellular Biochemistry, Vol. 93, Issue 1
Gene expression in bladder tumors
patent, August 2005
- Orntoft, Torben Falck
- US Patent Document 6,936,417
Three Biomarkers Identified from Serum Proteomic Analysis for the Detection of Early Stage Ovarian Cancer
journal, August 2004
- Zhang, Zhen; Bast, Robert C.; Yu, Yinhua
- Cancer Research, Vol. 64, Issue 16
Elevated Serum Insulin-Like Growth Factor Binding Protein-2 as a Prognostic Marker in Patients with Ovarian Cancer
journal, March 2004
- Baron-Hay, S.
- Clinical Cancer Research, Vol. 10, Issue 5
Ovarian cancer screening
journal, August 2003
- Urban, Nicole; McIntosh, Martin W.; Andersen, Marin (Robyn)
- Hematology/Oncology Clinics of North America, Vol. 17, Issue 4, p. 989-1005
Gene expression in bladder tumors
patent, January 2002
- Orntoft, Torben Falck
- US Patent Document 6,335,170
Methods and kits for diagnosing and determination of the predisposition for diseases
patent, May 2001
- Feinberg, Andrew P.
- US Patent Document 6,235,474
Leptin directly stimulates aromatase activity in human luteinized granulosa cells
journal, August 1999
- Kitawaki, J.
- Molecular Human Reproduction, Vol. 5, Issue 8
Circulating levels of insulin-like growth factor-II and IGF-binding protein 3 in cervical cancer
journal, December 2003
- Mathur, Subbi P.; Mathur, Rajesh S.; Underwood, Paul B.
- Gynecologic Oncology, Vol. 91, Issue 3, p. 486-493
Methods and compositions for diagnosing or monitoring auto immune and chronic inflammatory diseases
patent, June 2005
- Wohlgemuth, Jay; Fry, Kirk; Woodward, Robert
- US Patent Document 6,905,827
Fasting Ghrelin Levels in Physically Active Women: Relationship with Menstrual Disturbances and Metabolic Hormones
journal, July 2004
- De Souza, Mary Jane; Leidy, Heather J.; O’Donnell, Emma
- The Journal of Clinical Endocrinology & Metabolism, Vol. 89, Issue 7
Preoperative Sensitivity and Specificity for Early-Stage Ovarian Cancer When Combining Cancer Antigen CA-125II, CA 15-3, CA 72-4, and Macrophage Colony-Stimulating Factor Using Mixtures of Multivariate Normal Distributions
journal, October 2004
- Skates, Steven J.; Horick, Nora; Yu, Yinhua
- Journal of Clinical Oncology, Vol. 22, Issue 20
Leptin expression in colorectal and breast cancer patients.
journal, April 2000
- Tessitore, L.; Vizio, B.; Jenkins, O.
- International Journal of Molecular Medicine
Therapeutic Implications of Immune-endocrine Interactions in the Critically Ill Patients
journal, June 2004
- Oberbeck, Reiner
- Current Drug Targets - Immune, Endocrine & Metabolic Disorders, Vol. 4, Issue 2
Diagnostic marker for tumor hypoxia and prognosis
patent-application, March 2003
- Giaccia, Amato J.; Le, Quynh Thu; Denko, Nicholas C.
- US Patent Application 10/175440; 20030044862
Prolactin as a tumour marker in cancer of the cervix
journal, January 1998
- G. Perumal, J. Moodley, R. J. Pegor, B.
- Journal of Obstetrics and Gynaecology, Vol. 18, Issue 3
Differential gene expression profiling in human brain tumors
journal, February 2001
- Markert, James M.; Fuller, Catherine M.; Gillespie, G. Yancey
- Physiological Genomics, Vol. 5, Issue 1
Multiple Kinase Cascades Mediate Prolactin Signals to Activating Protein-1 in Breast Cancer Cells
journal, December 2004
- Gutzman, Jennifer H.; Rugowski, Debra E.; Schroeder, Matthew D.
- Molecular Endocrinology, Vol. 18, Issue 12
Growth Factor Signaling Induces Metastasis Genes in Transformed Cells: Molecular Connection between Akt Kinase and Osteopontin in Breast Cancer
journal, August 2003
- Zhang, G.; He, B.; Weber, G. F.
- Molecular and Cellular Biology, Vol. 23, Issue 18
Leptin and prolactin modulate the expression of SOCS-1 in association with interleukin-6 and tumor necrosis factor-α in mammary cells: a role in differentiated secretory epithelium
journal, September 2004
- Motta, M.; Accornero, P.; Baratta, M.
- Regulatory Peptides, Vol. 121, Issue 1-3, p. 163-170
Elevation of Multiple Serum Markers in Patients With Stage I Ovarian Cancer
journal, November 1993
- Woolas, R. P.; Xu, F. -J.; Jacabs, I. J.
- JNCI Journal of the National Cancer Institute, Vol. 85, Issue 21
Osteopontin as an Adjunct to CA125 in Detecting Recurrent Ovarian Cancer
journal, May 2004
- Schorge, J. O.
- Clinical Cancer Research, Vol. 10, Issue 10
Cancer screening in a high risk population: a clinical trial
journal, April 2001
- Taylor, Kenneth J. W.; Schwartz, Peter E.
- Ultrasound in Medicine & Biology, Vol. 27, Issue 4, p. 461-466
Detection of neoplasms by hormonal tumor stimulation test
patent, December 1996
- Altchek, Albert; Balkin, Michael S.
- US Patent Document 5,583,110
Identification of cancer protein biomarkers using proteomic techniques
patent, October 2016
- Mor, Gil G.; Ward, David C.; Bray-Ward, Patricia
- US Patent Document 9,470,688
Method for inhibiting neoplastic disease in mammals
patent, June 2000
- Cincotta, Anthony H.; Meier, Albert H.
- US Patent Document 6,071,914
Identification of cancer protein biomarkers using proteomic techniques
patent, February 2010
- Mor, Gil G.; Ward, David C.; Bray-Ward, Patricia
- US Patent Document 7,666,583
Obesity, adipocytokines, and insulin resistance in breast cancer
journal, August 2004
- Rose, D. P.; Komninou, D.; Stephenson, G. D.
- Obesity Reviews, Vol. 5, Issue 3
Ovarian cancer screening
journal, August 2004
- Menon, U.
- Canadian Medical Association Journal, Vol. 171, Issue 4
Diagnostic Markers for Early Detection of Ovarian Cancer
journal, February 2008
- Visintin, I.; Feng, Z.; Longton, G.
- Clinical Cancer Research, Vol. 14, Issue 4
Methods and compositions for diagnosing and monitoring transplant rejection
patent, June 2007
- Wohlgemuth, Jay; Fry, Kirk; Woodward, Robert
- US Patent Document 7,235,358
The Functional and Clinical Roles of Osteopontin in Cancer and Metastasis
journal, November 2001
- Kara A. Furger,
- Current Molecular Medicine, Vol. 1, Issue 5
Selection of Potential Markers for Epithelial Ovarian Cancer with Gene Expression Arrays and Recursive Descent Partition Analysis
journal, May 2004
- Lu, K. H.
- Clinical Cancer Research, Vol. 10, Issue 10
Menstrual Cycle Dependent Variability for Serum Tumor Markers CEA, AFP, CA 19-9, CA 125 and CA 15-3 in Healthy Women
journal, January 1999
- Erbağci, Ayşe Binnur; Yilmaz, Necat; Kutlar, Irfan
- Disease Markers, Vol. 15, Issue 4
Ghrelin inhibits leptin- and activation-induced proinflammatory cytokine expression by human monocytes and T cells
journal, July 2004
- Dixit, Vishwa Deep; Schaffer, Eric M.; Pyle, Robert S.
- Journal of Clinical Investigation, Vol. 114, Issue 1
Use of serum prolactin for monitoring the therapeutic response in ovarian malignancy
journal, September 1991
- Jha, P.; Farooq, A.; Rao, D. L.
- International Journal of Gynecology & Obstetrics, Vol. 36, Issue 1, p. 33-38
Downregulation of long-form prolactin receptor mRNA during prolactin-induced luteal regression
journal, August 2000
- Bowen, Jm; Telleria, Cm; Towns, R.
- European Journal of Endocrinology
Insulin-Like Growth Factor (IGF)-I and IGF-II Serum Concentrations in Patients with Benign and Malignant Breast Lesions: Free IGF-II Is Correlated with Breast Cancer Size
journal, June 2004
- Singer, C. F.
- Clinical Cancer Research, Vol. 10, Issue 12
Osteopontin as a Potential Diagnostic Biomarker for Ovarian Cancer
journal, April 2002
- Kim, Jae-Hoon; Skates, Steven J.; Uede, Toshimitsu
- JAMA, Vol. 287, Issue 13, p. 1671-1679
Role of osteopontin in tumour progression
journal, April 2004
- Rittling, S. R.; Chambers, A. F.
- British Journal of Cancer, Vol. 90, Issue 10
Gene expression profiles in primary ovarian serous papillary tumors and normal ovarian epithelium: Identification of candidate molecular markers for ovarian cancer diagnosis and therapy
journal, August 2004
- Santin, Alessandro D.; Zhan, Fenghuang; Bellone, Stefania
- International Journal of Cancer, Vol. 112, Issue 1
Use of proteomic patterns in serum to identify ovarian cancer
journal, February 2002
- Petricoin, Emanuel F.; Ardekani, Ali M.; Hitt, Ben A.
- The Lancet, Vol. 359, Issue 9306
Multiplexed Immunobead-Based Cytokine Profiling for Early Detection of Ovarian Cancer
journal, April 2005
- Gorelik, E.
- Cancer Epidemiology Biomarkers & Prevention, Vol. 14, Issue 4
Serum Vascular Endothelial Growth Factor and Serum Leptin in Patients with Cervical Cancer
journal, April 2002
- Lebrecht, Antje; Ludwig, Elisabeth; Huber, Ambros
- Gynecologic Oncology, Vol. 85, Issue 1
Differential Gene Expression in Chemically Induced Mouse Lung Adenomas
journal, January 2003
- Yao, Ruisheng; Wang, Yian; Lubet, Ronald A.
- Neoplasia, Vol. 5, Issue 1, p. 41-52
Serum protein markers for early detection of ovarian cancer
journal, May 2005
- Mor, G.; Visintin, I.; Lai, Y.
- Proceedings of the National Academy of Sciences, Vol. 102, Issue 21, p. 7677-7682